申请人:Fujisawa Pharmaceutical Co., Ltd.
公开号:US04214094A1
公开(公告)日:1980-07-22
The present invention relates to new substituted-phenyl substituted-alkyl ethers and pharmaceutically acceptable salts thereof, which have hypolipidemic activity, and to processes for the preparation thereof, the compound having the following formula ##STR1## wherein R.sub.1 is lower alkyl, cycloalkyl, aryl, ar(lower)alkyl, a heterocyclic group or a group represented by the formula: ##STR2## wherein R.sub.3 and R.sub.4 are each hydrogen or lower alkyl, R.sub.5 is carboxy, esterified carboxy or hydroxymethyl and A is lower alkylene; R.sub.2 is hydrogen, lower alkyl, cycloalkyl, aryl, ar(lower)alkyl, a heterocyclic group or a group represented by the formula: ##STR3## and R.sub.6 is hydrogen, hydroxy or lower alkoxy; in which the aryl or the ar(lower)alkyl for R.sub.1 and R.sub.2 may be substituted with halogen, hydroxy or lower alkoxy, and when R.sub.1 and R.sub.2 are both lower alkyl, R.sub.1 and R.sub.2 may be linked together.
本发明涉及新的取代苯基取代烷基醚及其药用盐,具有降脂活性,并涉及其制备方法,该化合物具有以下结构式
其中R.sub.1为较低烷基,环烷基,芳基,芳基(较低)烷基,杂环基团或由以下结构式表示的基团:
其中R.sub.3和R.sub.4各自为氢或较低烷基,R.sub.5为羧基,酯化羧基或羟甲基,A为较低烷基;R.sub.2为氢,较低烷基,环烷基,芳基,芳基(较低)烷基,杂环基团或由以下结构式表示的基团:
R.sub.6为氢,羟基或较低烷氧基;其中R.sub.1和R.sub.2的芳基或芳基(较低)烷基可以被卤素,羟基或较低烷氧基取代,当R.sub.1和R.sub.2都是较低烷基时,R.sub.1和R.sub.2可以连接在一起。